RESERPINE
Drugs in Pregnancy and Lactation.
"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. |
Name: RESERPINE
Class: Antihypertensive
Risk Factor: CM
Fetal Risk Summary
The Collaborative Perinatal Project monitored 50,282 mother-child pairs, 48 of which had 1st trimester exposure to reserpine (1, p. 376). There were four defects with 1st trimester use. Although this incidence (8%) is greater than the expected frequency of occurrence, no major category or individual malformations were identified. For use anytime in pregnancy, 475 exposures were recorded (1, p. 441). Malformations included the following:
Microcephaly (7 cases)
Hydronephrosis (3 cases)
Hydroureter (3 cases)
Inguinal hernia (12 cases)
Incidence of these latter malformations was not found to be statistically significant (1, p. 495).
Reserpine crosses the placenta. Use of reserpine near term has resulted in nasal discharge, retraction, lethargy, and anorexia in the newborn (2). Concern over the ability of reserpine to deplete catecholamine levels has appeared (3). The significance of this is not known.
In a surveillance study of Michigan Medicaid recipients involving 229,101 completed pregnancies conducted between 1985 and 1992, 15 newborns had been exposed to reserpine during the 1st trimester (F. Rosa, personal communication, FDA, 1993). No major birth defects were observed (one expected).
Breast Feeding Summary
Reserpine is excreted into breast milk (4). No clinical reports of adverse effects in the nursing infant have been located.
"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. |
References
- Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977.
- Budnick IS, Leikin S, Hoeck LE. Effect in the newborn infant to reserpine administration ante partum. Am J Dis Child 1955;90:286–9.
- Towell ME, Hyman AI. Catecholamine depletion in pregnancy. J Obstet Gynaecol Br Commonw 1966;73:431–8.
- Product information. Serpasil. Ciba Pharmaceutical, 1993.
Q&A about Reserpine
The pattern of weight gain amongst Schizophrenics on administration of reserpine
Your question is?
